LXRX实时信号 | 通过Getagraph.com最大化利润

购买 107360 min ago

@ $3.29

发出时间: 15 Feb 2024 @ 02:44

回报率: -51.98%

上一信号: Feb 14 - 22:31

上一信号: 出售

回报率: 4.44 %

Live Chart Being Loaded With Signals

Commentary (27 Apr 2024 @ 04:00):

Stats
今日成交量	1.27M
平均成交量	4.56M
市值	389.05M
EPS	$0 ( 2024-03-07 )
下一个收益日期	( $-0.200 ) 2024-05-07
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.970
ATR14	$0.00400 (0.25%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-13	Artal International S.c.a.	Buy	1 150 922	Series A Convertible Preferred Stock
2024-02-28	Alexander Kristen	Buy	15 927	Common Stock
2024-02-28	Alexander Kristen	Sell	11 793	Common Stock
2024-02-28	Alexander Kristen	Buy	10 616	Common Stock
2024-02-28	Alexander Kristen	Buy	2 700	Common Stock

INSIDER POWER
92.57
Last 98 transactions
Buy: 35 947 123 \| Sell: 970 903

音量相关性

長: -0.16 (neutral)

短: -0.55 (weak negative)

Signal:(41.861) Neutral

Lexicon Pharmaceuticals 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Lexicon Pharmaceuticals 相关性 - 货币/商品

-0.09
( neutral )

-0.07
( neutral )

0.00
( neutral )

0.15
( neutral )

Lexicon Pharmaceuticals 财务报表

Annual	2023
营收:	$1.20M
毛利润:	$565 000 (46.93 %)
EPS:	$-0.800

FY	2023
营收:	$1.20M
毛利润:	$565 000 (46.93 %)
EPS:	$-0.800

FY	2022
营收:	$139 000
毛利润:	$-288 000 (-207.19 %)
EPS:	$-0.620

FY	2021
营收:	$298 000
毛利润:	$298 000 (100.00 %)
EPS:	$-0.602

Financial Reports:

No articles found.

Lexicon Pharmaceuticals

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II clinical development for the treatment of neuropathic pain. The company has strategic collaboration and license agreements with Bristol-Myers Squibb Company, and Genentech, Inc. Lexicon Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in The Woodlands, Texas.